JP2001502534A5 - - Google Patents

Download PDF

Info

Publication number
JP2001502534A5
JP2001502534A5 JP1998517538A JP51753898A JP2001502534A5 JP 2001502534 A5 JP2001502534 A5 JP 2001502534A5 JP 1998517538 A JP1998517538 A JP 1998517538A JP 51753898 A JP51753898 A JP 51753898A JP 2001502534 A5 JP2001502534 A5 JP 2001502534A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998517538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001502534A (ja
JP4160121B2 (ja
Filing date
Publication date
Priority claimed from US08/710,305 external-priority patent/US5801012A/en
Application filed filed Critical
Publication of JP2001502534A publication Critical patent/JP2001502534A/ja
Publication of JP2001502534A5 publication Critical patent/JP2001502534A5/ja
Application granted granted Critical
Publication of JP4160121B2 publication Critical patent/JP4160121B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51753898A 1996-09-17 1997-09-17 アンジオスタチン生成のための方法及び組成物 Expired - Fee Related JP4160121B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/710,305 US5801012A (en) 1996-09-17 1996-09-17 Methods and compositions for generating angiostatin
US08/710,305 1996-09-17
PCT/US1997/016539 WO1998015574A1 (en) 1996-09-17 1997-09-17 Methods and compositions for generating angiostatin

Publications (3)

Publication Number Publication Date
JP2001502534A JP2001502534A (ja) 2001-02-27
JP2001502534A5 true JP2001502534A5 (https=) 2005-05-12
JP4160121B2 JP4160121B2 (ja) 2008-10-01

Family

ID=24853480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51753898A Expired - Fee Related JP4160121B2 (ja) 1996-09-17 1997-09-17 アンジオスタチン生成のための方法及び組成物

Country Status (9)

Country Link
US (2) US5801012A (https=)
EP (2) EP0964869B1 (https=)
JP (1) JP4160121B2 (https=)
AT (1) ATE329926T1 (https=)
AU (1) AU4422797A (https=)
CA (1) CA2265550A1 (https=)
DE (1) DE69736129T2 (https=)
ES (1) ES2267151T3 (https=)
WO (1) WO1998015574A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
JP2002510209A (ja) * 1997-06-26 2002-04-02 カロリンスカ イノベイションズ アクチボラゲット インビボで血管形成を調節することができるプラスミノーゲンのクリングルドメイン1−5
CA2352477A1 (en) * 1998-11-25 2000-06-02 Richard-Weidong Ji Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
CA2384929C (en) 1999-09-15 2006-12-05 Mogam Biotechnology Research Institute A novel angiogenesis inhibitor
EP1263452A4 (en) * 2000-02-08 2006-12-20 Univ Northwestern METHODS AND COMPOSITIONS FOR PRODUCING ANGIOSTATIN
AU8591901A (en) 2000-09-05 2002-03-22 Karolinska Innovations Ab Materials and methods relating to endothelial cell growth inhibitors
AU2002239366A1 (en) 2000-11-28 2002-06-11 Geetha Kassam Anti-angiogenic polypeptides
ITMI20011995A1 (it) * 2001-09-26 2003-03-26 Ist Naz Ricerca Sul Cancro Sostanze ad attivita' antinfiammatoria
US7285277B2 (en) * 2002-03-15 2007-10-23 Mogam Biotechnology Research Institute Anticancer agent
WO2004005248A1 (en) * 2002-07-02 2004-01-15 Novartis Ag Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
EP1581164A4 (en) * 2002-12-13 2008-03-12 Mediomics Llc COMPOSITIONS AND METHODS FOR INHIBITING GROWTH OF TUMORS AND METASTASES
US7090654B2 (en) * 2003-03-28 2006-08-15 Sherwood Services Ag Catheter with occlusion resistant tip
US7141035B2 (en) * 2003-03-28 2006-11-28 Sherwood Services Ag Catheter with occlusion resistant tip
US7776005B2 (en) * 2003-03-28 2010-08-17 Covidien Ag Triple lumen catheter with occlusion resistant tip
US20050281879A1 (en) * 2003-11-14 2005-12-22 Guohua Chen Excipients in drug delivery vehicles
CN1889929B (zh) * 2003-11-14 2013-04-10 阿尔萨公司 药物递送媒介物中的赋形剂
EP1814610B1 (en) 2004-11-04 2020-05-06 Covidien AG Catheter insertion apparatus
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2009100617A1 (zh) * 2008-02-04 2009-08-20 Shanghai First People's Hospital 抑制血管新生的多肽及其应用
WO2010151573A1 (en) 2009-06-26 2010-12-29 Tyco Healthcare Group Lp Catheterization system
CA2715857A1 (en) 2009-09-30 2011-03-30 Tyco Healthcare Group Lp Medical catheter having a design providing low recirculation and reversibility
US8747343B2 (en) 2011-09-30 2014-06-10 Covidien Lp Hemodialysis catheter with improved side opening design
US9072867B2 (en) 2011-09-30 2015-07-07 Covidien Lp Catheter with external flow channel
JP2015003902A (ja) 2013-05-20 2015-01-08 杏林製薬株式会社 血管新生阻害剤
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
US4968494A (en) * 1987-03-27 1990-11-06 Merck & Co., Inc. Methods and compositions for thrombolytic therapy
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5021404A (en) 1988-04-20 1991-06-04 The Children's Medical Center Corporation Angiostatic collagen modulators
EP0682020A1 (en) 1988-09-01 1995-11-15 Takeda Chemical Industries, Ltd. Fumagillol derivatives useful as angiogenesis inhibitors
PT93847A (pt) 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US5290807A (en) 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
US5192744A (en) 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
ATE355379T1 (de) 1994-04-26 2006-03-15 Childrens Medical Center Angiostatin und verfahren zu seiner nutzung zur vermeidung der angiogenese
US5945403A (en) 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
NZ307044A (en) 1995-04-26 2002-03-01 Childrens Medical Center Angiostatin fragments with antiangiogenic activity
US5861372A (en) 1996-02-22 1999-01-19 The Children's Medical Center Corporation Aggregate angiostatin and method of use
AU6264596A (en) 1995-06-07 1996-12-30 Children's Medical Center Corporation Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
JP3840262B2 (ja) 1995-10-23 2006-11-01 ザ チルドレンズ メディカル センター コーポレイション 治療用の抗血管新生組成物および方法
CZ298612B6 (cs) 1995-12-13 2007-11-21 The Children's Medical Center Corporation Inhibitor proliferace endothelových bunek a jeho použití
US5854221A (en) 1996-12-12 1998-12-29 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
US6057122A (en) 1996-05-03 2000-05-02 Abbott Laboratories Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
JP2002510209A (ja) 1997-06-26 2002-04-02 カロリンスカ イノベイションズ アクチボラゲット インビボで血管形成を調節することができるプラスミノーゲンのクリングルドメイン1−5

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501018A5 (https=)
JP2000501324A5 (https=)
JP2000507075A5 (https=)
JP2000502472A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2000515570A5 (https=)
JP2000502485A5 (https=)
JP2001505521A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000508673A5 (https=)
JP2000504793A5 (https=)
JP2000501229A5 (https=)
JP2000502316A5 (https=)
JP2000500857A5 (https=)
JP2000502714A5 (https=)
JP2000500184A5 (https=)
JP2001502534A5 (https=)
JP2000505695A5 (https=)
JP2000500318A5 (https=)